Published in Obstet Gynecol on February 01, 1967
Microsatellite instability in human solid tumors. Cancer (1998) 1.94
Epidemiology of cancer of the ovary. Cancer (1969) 1.40
Relative prognostic significance of preoperative and operative findings in pelvic exenteration. Surg Clin North Am (1969) 1.17
Gynecological tumors in childhood and adolescence. Obstet Gynecol Surv (1973) 1.13
Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer. Am J Obstet Gynecol (1975) 1.07
External vs. interstitial irradiation in unresectable recurrent cancer of the cervix. Cancer (1971) 0.99
Newlywed apareunia. Obstet Gynecol (1969) 0.98
Excision of major blood vessels at the periphery of the pelvis in patients receiving pelvic exenteration: common and/or iliac arteries and veins 1947 to 1964. Surgery (1967) 0.97
Pelvic exenteration for locally advanced and recurrent ovarian cancer. Review of 22 cases. Surgery (1965) 0.96
Torsion of normal uterine adnexa in children. Report of three cases. Obstet Gynecol (1970) 0.91
Pregnancy and delivery after previous bilateral total adrenalectomy. Obstet Gynecol (1966) 0.90
Definitive treatment of radiation necrosis. 5-year results in 77 patients. Obstet Gynecol (1970) 0.86
Tissue cultures of ovarian carcinomas. Lab Invest (1974) 0.86
The effect of cancer and its therapy upon fertility. Int J Fertil (1981) 0.85
Symposium on gynecologic cancer: foreword. Surg Clin North Am (1978) 0.85
bcl-2 and p53 in endometrial adenocarcinoma. Mod Pathol (1997) 0.83
Urinary tract fistulas following pelvic exenteration. Obstet Gynecol (1966) 0.83
Isolation of tumor-specific antibodies from effusions of ovarian carcinomas. Int J Cancer (1975) 0.83
Secondary and tertiary rediversion of the urinary tract. A study based upon 72 cases among 840 pelvic exenterations for advanced cancer. JAMA (1968) 0.83
Incidence of carcinoma in the retained ovary. Am J Surg (1967) 0.82
Fetal and neonatal effects of cytotoxic agents. Obstet Gynecol (1981) 0.82
Ovarian cancer: diagnosis and management. Am J Obstet Gynecol (1984) 0.82
Augmented labor. Obstet Gynecol (1972) 0.81
Lymphadenectomy in pelvic exenteration for recurrent cervix cancer. JAMA (1971) 0.81
Pelvic exenteration combined with resection of segments of bony pelvis. Surgery (1969) 0.80
Cellular immunologic responsiveness to extracts of ovarian epithelial tumors. Gynecol Oncol (1975) 0.80
Immunology in tumor therapeutics: an overview. Del Med J (1980) 0.80
Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy. Obstet Gynecol (1974) 0.79
Ovarian cancer. CA Cancer J Clin (1986) 0.79
Operative management of patients previously operated upon for a benign lesion with cervical cancer as a suprise finding. Am J Obstet Gynecol (1968) 0.79
Description of an endometrioid ovarian cancer cell line. Gynecol Oncol (1989) 0.78
Ovarian cancer, Part II. CA Cancer J Clin (1980) 0.78
Ovarian cancer. CA Cancer J Clin (1975) 0.77
P53 expression in adenomyosis in endometrial carcinoma patients. Gynecol Oncol (1996) 0.77
The critically ill patient with gynecologic cancer. Clin Obstet Gynecol (1985) 0.77
Electron microscopy, tissue culture,and immunology of ovarian carcinoma. Natl Cancer Inst Monogr (1975) 0.77
The role of surgery in carcinoma of the ovary. Bull N Y Acad Med (1983) 0.75
Treatment of advanced cancer of the cervix by pelvic exenteration. Bull N Y Acad Med (1973) 0.75
Spread and treatment of advanced ovarian cancer. Baillieres Clin Obstet Gynaecol (1989) 0.75
Ovarian cancer in children--guide for a difficult decision. CA Cancer J Clin (1976) 0.75
Stress incontinenece in women: a review--1977. Obstet Gynecol Surv (1977) 0.75
Septic shock in obstetrics and gynecology. Minn Med (1970) 0.75
The intestinal tract in relation to obstetrics and gynecology. Clin Obstet Gynecol (1972) 0.75
Surgical treatment of carcinoma of the cervix. Obstet Gynecol (1966) 0.75
Ovarian cancer: immunologic diagnosis and therapy. Contrib Gynecol Obstet (1985) 0.75
Contraceptives versus abortifacients. Female Patient (1990) 0.75
Recurrent cervical cancer after treatment by a primary surgical program. Obstet Gynecol (1971) 0.75
Our approach to cancer of the cervix. Med Times (1972) 0.75
Total pelvic exenteration. Cancer (1998) 0.75
Early diagnosis of ovarian cancer. Clin Obstet Gynecol (1969) 0.75
Cervical cancer: pelvic and para-aortic lymph node sampling and its consequences. Baillieres Clin Obstet Gynaecol (1988) 0.75
The training of the gynecologist. Obstet Gynecol (1982) 0.75
A clinical test for prenancy. Am J Obstet Gynecol (1970) 0.75
Current status of the treatment of gynecologic cancer by site: ovary. Cancer (1976) 0.75
Gynecologic cancer. Early diagnosis: the physician's responsibility. Northwest Med (1968) 0.75
The case for and against estrogen therapy. Am J Nurs (1975) 0.75
Symposium on ovarian tumors. Foreword. Clin Obstet Gynecol (1969) 0.75
[Pelvic evisceration in therapy of recurrent and advanced cancer of the vulva and of the vagina. Apropos of 74 cases operated on at the New York Memorial-James Ewing Hospitals]. Ann Ostet Ginecol Med Perinat (1968) 0.75
Critique. Clin Obstet Gynecol (1976) 0.75
Bladder mobilization in hysterectomy. Obstet Gynecol (1967) 0.75
A surgical approach to endometrial sarcoma. Left inferior pulmonary lobectomy for metastases 8 1/2 years after anterior pelvic exenteration. Obstet Gynecol (1965) 0.75
Ovarian Cancer. CA Cancer J Clin (1975) 0.75
Immunohistochemical characterization of a monoclonal antibody detecting an endometrioid ovarian cancer-associated antigen. Int J Gynecol Pathol (1990) 0.75
An update on DES in the field of reproduction. Int J Fertil (1986) 0.75
The making of a gynecologic oncologist. Eur J Gynaecol Oncol (2000) 0.75
Ureteral carcinoma as a gynecologic problem. Report of a case. Obstet Gynecol (1968) 0.75
Urinary incontinence. Clin Obstet Gynecol (1996) 0.75
The PMPO syndrome (postmenopausal palpable ovary syndrome). Obstet Gynecol (1971) 0.75
Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies. Gynecol Oncol (1990) 0.75
A time to keep silence and a time to speak. Obstet Gynecol (1966) 0.75
Symposium on endometrial carcinoma. Classification, grading, and staging. Pathol Annu (1985) 0.75
Ovarian cancer: cause, diagnosis, and treatment. Compr Ther (1987) 0.75
Ovarian cancers in childhood. Int J Radiat Oncol Biol Phys (1982) 0.75
Treatment and results of recurrent cancer of corpus uteri in patients receiving anterior and total pelvic exenteration 1947-1963. Cancer (1968) 0.75
Carcinoma of the bowel. Radiation and surgical management and pregnancy. Am J Obstet Gynecol (1968) 0.75
Cancer of the endometrium. R I Med J (1975) 0.75
The PMPO syndrome (postmenopausal palpable ovary syndrome). CA Cancer J Clin (1973) 0.75
Cancer of the endometrium. Tex Med (1974) 0.75
Abdominovaginal delivery: modification of the cesarean section operation to facilitate delivery of the impacted head. Am J Obstet Gynecol (1984) 0.75
Intrauterine growth retardation: diagnosis and management. Diagn Gynecol Obstet (1982) 0.75